RetinalGenix Technologies Inc. (RTGN)

USD 53.0

(88.0%)

Total Debt Summary of RetinalGenix Technologies Inc.

  • RetinalGenix Technologies Inc.'s latest annual total debt in 2023 was 506.53 Thousand USD , up 933.74% from previous year.
  • RetinalGenix Technologies Inc.'s latest quarterly total debt in 2024 Q2 was 49 Thousand USD , down 0.0% from previous quarter.
  • RetinalGenix Technologies Inc. reported annual total debt of 49 Thousand USD in 2022, down -32.88% from previous year.
  • RetinalGenix Technologies Inc. reported annual total debt of 73 Thousand USD in 2021, down 0.0% from previous year.
  • RetinalGenix Technologies Inc. reported quarterly total debt of 49 Thousand USD for 2024 Q1, down 0.0% from previous quarter.
  • RetinalGenix Technologies Inc. reported quarterly total debt of 49 Thousand USD for 2023 Q2, down 0.0% from previous quarter.

Annual Total Debt Chart of RetinalGenix Technologies Inc. (2023 - 2018)

Historical Annual Total Debt of RetinalGenix Technologies Inc. (2023 - 2018)

Year Total Debt Total Debt Growth
2023 506.53 Thousand USD 933.74%
2022 49 Thousand USD -32.88%
2021 73 Thousand USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%

Peer Total Debt Comparison of RetinalGenix Technologies Inc.

Name Total Debt Total Debt Difference
Acutus Medical, Inc. 38.47 Million USD 98.684%
Biotricity, Inc. 23.87 Million USD 97.879%
Cell MedX Corp. 287.46 Thousand USD -76.207%
Dynatronics Corporation 6.68 Million USD 92.426%
Nemaura Medical Inc. 20.03 Million USD 97.471%
PetVivo Holdings, Inc. 1.36 Million USD 62.892%
Sonendo, Inc. 40.35 Million USD 98.745%
Telesis Bio, Inc. 34.38 Million USD 98.527%
Talis Biomedical Corporation 19.66 Million USD 97.425%
Viveve Medical, Inc. 5.34 Million USD 90.53%